MedWatch

Lundbeck wants to test medicine on grasshoppers

The brain of the blue-winged grasshopper is remarkably similar to that of a human being, and Lundbeck wants to take advantage of that to develop medicine. Tests with the insects will be far cheaper and faster than with mice – and less ethically challenging.

As the first ever, the Danish company Lundbeck will use grasshoppers for drug testing in a development project that should lead to a new drug for Alzheimer’s. The brain of the grasshopper is so similar to that of a human that the pharmaceutical group have decided to use the winged creatures for clinical studies.

If the model proves successful, grasshoppers could be used for the development of drugs for all manner of diseases in the central nervous system, the Danish newspaper Berlingske reports.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier